MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202547058829 A) filed by Green Cross Corporation, Gyeonggi, Republic of Korea, on June 19, for 'pharmaceutical composition comprising heparan n-sulfatase with improved stability.'
Inventor(s) include Yang, Taeseung; Kim, Miroo; Son, Jaewoon; Yoo, Miri; Lee, Miso; and Jin, Dong Kyu.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a pharmaceutical composition of a high concentration of heparan N-sulfatase (HNS) with enhanced stability for CNS delivery and a pharmaceutical formulation comprising the same. The pharma...